KEY FINDINGS
The Asia-Pacific immunoglobulin market is estimated to grow with a CAGR of 7.20% during the forecast period of 2022 to 2030. The market growth of the region is fuelled by the launch of advanced and innovative immunoglobulin products, the rise in the geriatric population, and the increasing incidence of various disease types.
MARKET INSIGHTS
The Asia-Pacific immunoglobulin market growth assessment entails the evaluation of China, South Korea, Indonesia, Vietnam, Japan, India, Australia, Thailand, and Rest of Asia-Pacific. Key players are engaged in the launch and development of innovative immunoglobulin products in India. For example, Cipla, in 2021, launched Roche's COVID antibody cocktail (Imdevimab and Casirivimab) in the country. It is administered for treating moderate to mild COVID-19 in adults and pediatric patients. Casirivimab, as well as Imdevimab, entail human immunoglobulin G-1 (IgG1) monoclonal antibodies produced by recombinant DNA technology in laboratories.
Conversely, there has been a substantial rise in healthcare expenditure in Indonesia. As a result, patients experiencing various types of immunodeficiency diseases and other rare conditions gain fast and easy access to technologically advanced and novel healthcare facilities. Moreover, this factor not only helps in the effective diagnosis but also facilitates improved treatment for numerous disease types. Therefore, these factors are anticipated to propel the market growth in the Asia-Pacific during the forecast period.
COMPETITIVE INSIGHTS
Prominent companies operating in the market include Sichuan Yuanda Shuyang Pharmaceutical Co Ltd, Takeda Pharmaceutical Company Limited, Shanghai RAAS Blood Products Co Ltd, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation cater to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Asia-Pacific Immunoglobulin Market Forecast 2022-2030
Table Of Contents
1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Key Drivers
3.1.1. Growth In Geriatric Population
3.1.2. Prevalence Of Immunodeficiency Diseases And Autoimmune Disorders
3.1.3. Increasing Research And Development Activities
3.2. Key Restraints
3.2.1. High Cost Of Therapy
3.2.2. High Risk Of Side Effects
4. Key Analytics
4.1. Impact Of Covid-19 On Immunoglobulin Market
4.2. Key Market Trends
4.3. Porter's Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Key Buying Criteria
4.6.1. Source
4.6.2. Application
4.6.3. Epitope
4.6.4. Validation
4.7. Regulatory Framework
5. Market By Product
5.1. Igg
5.2. Iga
5.3. Igm
5.4. Ige
5.5. Igd
6. Market By Mode Of Delivery
6.1. Intravenous Immunoglobulin
6.2. Subcutaneous Immunoglobulin
6.3. Intramuscular Immunoglobulin
7. Market By Application
7.1. Hypogamma Globulinemia
7.2. Chronic Inflammatory Demyelinating Polyneuropathy
7.3. Primary Immunodeficiency Diseases
7.4. Myasthenia Gravis
7.5. Multifocal Motor Neuropathy
7.6. Idiopathic Thrombocytopenic Purpura (Itp)
7.7. Inflammatory Myopathies
7.8. Specific Antibody Deficiency
7.9. Guillain-Barre Syndrome
7.10. Other Applications
8. Market By Distribution Channel
8.1. Hospital Pharmacy
8.2. Specialty Pharmacy
8.3. Other Distribution Channels
9. Market By End-User
9.1. Hospitals & Clinics
9.2. Homecare
10. Geographical Analysis
10.1. Asia-Pacific
10.1.1. Market Size & Estimates
10.1.2. Key Growth Enablers
10.1.3. Key Challenges
10.1.4. Key Players
10.1.5. Country Analysis
10.1.5.1. China
10.1.5.2. Japan
10.1.5.3. India
10.1.5.4. South Korea
10.1.5.5. Indonesia
10.1.5.6. Thailand
10.1.5.7. Vietnam
10.1.5.8. Australia
10.1.5.9. Rest Of Asia-Pacific
11. Competitive Landscape
11.1. Key Strategic Developments
11.1.1. Mergers & Acquisitions
11.1.2. Product Launches & Developments
11.1.3. Partnerships & Agreements
11.1.4. Business Expansions & Divestitures
11.2. Company Profiles
11.2.1. Adma Biologics
11.2.2. Bio Products Laboratory
11.2.3. Biotest Ag
11.2.4. China Biologic Products Inc
11.2.5. Csl Behring
11.2.6. Grifols Sa
11.2.7. Kamada Ltd
11.2.8. Kedrion Biopharma
11.2.9. Lfb Group
11.2.10. Octapharma Ag
11.2.11. Pfizer Inc
11.2.12. Sanquin Plasma Products Bv
11.2.13. Shanghai Raas Blood Products Co Ltd
11.2.14. Sichuan Yuanda Shuyang Pharmaceutical Co Ltd
11.2.15. Takeda Pharmaceutical Company Limited
List Of Tables
Table 1: Market Snapshot - Immunoglobulin
Table 2: Regulatory Framework
Table 3: Asia-Pacific Immunoglobulin Market, By Product, Historical Years 2018-2021 (In $ Million)
Table 4: Asia-Pacific Immunoglobulin Market, By Product, Forecast Years 2022-2030 (In $ Million)
Table 5: Asia-Pacific Immunoglobulin Market, By Mode Of Delivery, Historical Years 2018-2021 (In $ Million)
Table 6: Asia-Pacific Immunoglobulin Market, By Mode Of Delivery, Forecast Years 2022-2030 (In $ Million)
Table 7: Asia-Pacific Immunoglobulin Market, By Application, Historical Years 2018-2021 (In $ Million)
Table 8: Asia-Pacific Immunoglobulin Market, By Application, Forecast Years 2022-2030 (In $ Million)
Table 9: Asia-Pacific Immunoglobulin Market, By Distribution Channel, Historical Years 2018-2021 (In $ Million)
Table 10: Asia-Pacific Immunoglobulin Market, By Distribution Channel, Forecast Years 2022-2030 (In $ Million)
Table 11: Asia-Pacific Immunoglobulin Market, By End-User, Historical Years 2018-2021 (In $ Million)
Table 12: Asia-Pacific Immunoglobulin Market, By End-User, Forecast Years 2022-2030 (In $ Million)
Table 13: Asia-Pacific Immunoglobulin Market, By Country, Historical Years 2018-2021 (In $ Million)
Table 14: Asia-Pacific Immunoglobulin Market, By Country, Forecast Years 2022-2030 (In $ Million)
Table 15: Leading Players Operating In Asia-Pacific Immunoglobulin Market
Table 16: List Of Mergers & Acquisitions
Table 17: List Of Product Launches & Developments
Table 18: List Of Partnerships & Agreements
Table 19: List Of Business Expansions & Divestitures
List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter's Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Key Buying Criteria
Figure 6: Asia-Pacific Immunoglobulin Market, Growth Potential, By Product, In 2021
Figure 7: Asia-Pacific Immunoglobulin Market, By Igg, 2022-2030 (In $ Million)
Figure 8: Asia-Pacific Immunoglobulin Market, By Iga, 2022-2030 (In $ Million)
Figure 9: Asia-Pacific Immunoglobulin Market, By Igm, 2022-2030 (In $ Million)
Figure 10: Asia-Pacific Immunoglobulin Market, By Ige, 2022-2030 (In $ Million)
Figure 11: Asia-Pacific Immunoglobulin Market, By Igd, 2022-2030 (In $ Million)
Figure 12: Asia-Pacific Immunoglobulin Market, Growth Potential, By Mode Of Delivery, In 2021
Figure 13: Asia-Pacific Immunoglobulin Market, By Intravenous Immunoglobulin, 2022-2030 (In $ Million)
Figure 14: Asia-Pacific Immunoglobulin Market, By Subcutaneous Immunoglobulin, 2022-2030 (In $ Million)
Figure 15: Asia-Pacific Immunoglobulin Market, By Intramuscular Immunoglobulin, 2022-2030 (In $ Million)
Figure 16: Asia-Pacific Immunoglobulin Market, Growth Potential, By Application, In 2021
Figure 17: Asia-Pacific Immunoglobulin Market, By Hypogamma Globulinemia, 2022-2030 (In $ Million)
Figure 18: Asia-Pacific Immunoglobulin Market, By Chronic Inflammatory Demyelinating Polyneuropathy, 2022-2030 (In $ Million)
Figure 19: Asia-Pacific Immunoglobulin Market, By Primary Immunodeficiency Diseases, 2022-2030 (In $ Million)
Figure 20: Asia-Pacific Immunoglobulin Market, By Myasthenia Gravis, 2022-2030 (In $ Million)
Figure 21: Asia-Pacific Immunoglobulin Market, By Multifocal Motor Neuropathy, 2022-2030 (In $ Million)
Figure 22: Asia-Pacific Immunoglobulin Market, By Idiopathic Thrombocytopenic Purpura (Itp), 2022-2030 (In $ Million)
Figure 23: Asia-Pacific Immunoglobulin Market, By Inflammatory Myopathies, 2022-2030 (In $ Million)
Figure 24: Asia-Pacific Immunoglobulin Market, By Specific Antibody Deficiency, 2022-2030 (In $ Million)
Figure 25: Asia-Pacific Immunoglobulin Market, By Guillain-Barre Syndrome, 2022-2030 (In $ Million)
Figure 26: Asia-Pacific Immunoglobulin Market, By Other Applications, 2022-2030 (In $ Million)
Figure 27: Asia-Pacific Immunoglobulin Market, Growth Potential, By Distribution Channel, In 2021
Figure 28: Asia-Pacific Immunoglobulin Market, By Hospital Pharmacy, 2022-2030 (In $ Million)
Figure 29: Asia-Pacific Immunoglobulin Market, By Specialty Pharmacy, 2022-2030 (In $ Million)
Figure 30: Asia-Pacific Immunoglobulin Market, By Other Distribution Channels, 2022-2030 (In $ Million)
Figure 31: Asia-Pacific Immunoglobulin Market, Growth Potential, By End-User, In 2021
Figure 32: Asia-Pacific Immunoglobulin Market, By Hospitals & Clinics, 2022-2030 (In $ Million)
Figure 33: Asia-Pacific Immunoglobulin Market, By Homecare, 2022-2030 (In $ Million)
Figure 34: Asia-Pacific Immunoglobulin Market, Country Outlook, 2021 & 2030 (In %)
Figure 35: China Immunoglobulin Market, 2022-2030 (In $ Million)
Figure 36: Japan Immunoglobulin Market, 2022-2030 (In $ Million)
Figure 37: India Immunoglobulin Market, 2022-2030 (In $ Million)
Figure 38: South Korea Immunoglobulin Market, 2022-2030 (In $ Million)
Figure 39: Indonesia Immunoglobulin Market, 2022-2030 (In $ Million)
Figure 40: Thailand Immunoglobulin Market, 2022-2030 (In $ Million)
Figure 41: Vietnam Immunoglobulin Market, 2022-2030 (In $ Million)
Figure 42: Australia Immunoglobulin Market, 2022-2030 (In $ Million)
Figure 43: Rest Of Asia-Pacific Immunoglobulin Market, 2022-2030 (In $ Million)
Global Fibrinogen Concentrate Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 84
The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc.
The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030.
The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......
Global Fibrinogen Concentrate Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 91
According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period.
The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......
Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 124
Market Overview of Global Low Molecular Weight Heparin market:
According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years.
Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......
Global Anticoagulants Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 106
According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period.
The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......
Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 95
According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period.
The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......
Global Low Molecular Weight Heparin Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 88
According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period.
The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......
Global Heparin Sodium Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 132
According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period.
The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......
Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 120
According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period.
The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......
Global Heparin Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 128
According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period.
The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
